Medifast outlines Q4 2025 revenue guidance of $65M-$80M amid strategic shift to metabolic health solutions
Source: SeekingAlpha
2025-11-03 18:36:58 ET
More on Medifast
- Medifast, Inc. (MED) Q3 2025 Earnings Call Transcript
- Medifast, Inc. 2025 Q3 - Results - Earnings Call Presentation
- Medifast Q3 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Medifast
- Historical earnings data for Medifast
Read the full article on Seeking Alpha
For further details see:
Medifast outlines Q4 2025 revenue guidance of $65M–$80M amid strategic shift to metabolic health solutions
MEDIFAST INC
NASDAQ: MED
MED Trading
-1.67% G/L:
$10.625 Last:
108,612 Volume:
$10.73 Open:
MED Latest News
February 20, 2026 08:30:00 am
Scientific Evidence Demonstrates OPTAVIA®'s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
February 17, 2026 04:05:00 pm
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results
MED Stock Data
$125,190,599
10,672,526
2.58%
34
N/A
Personal Services
Consumer Discretionary
US
Baltimore
